Jacobs John C bought NVAX
March 1, 2024 · Form 4 insider transaction
Jacobs John C bought 250,000 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 25 days after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.00
Total value
N/A
InsiderJacobs John C
RoleOfficer, Director
CompanyNovavax, Inc. (NVAX)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 1, 2024
Filing dateMarch 26, 2024
Shares owned after250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.; One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 Grant Date, in each case subject to continued employment through such vesting date.